title: Influence of calcium on the proteolytic degradation of the calmodulin-like skin protein (calmodulin-like protein 5) in psoriatic epidermis.
abstract: The calmodulin-like skin protein (CLSP) or so-called calmodulin-like protein 5, a recently discovered skin-specific calcium-binding protein, is closely related to keratinocyte differentiation. The 16-kDa protein is proteolytically degraded in the upper layers of the stratum corneum (SC) of healthy skin. With the use of specific new monoclonal antibodies to CLSP, we were able to demonstrate that the abnormal elevated levels of CLSP, characteristic of psoriatic epidermis, were probably not due to an overexpression of the protein, but most likely the result of its non-degradation. Further in vitro experiments using recombinant CLSP and in situ data clearly showed that calcium protected and chelator accelerated CLSP degradation. These data indicate that CLSP degradation in the SC of psoriatic skin might be hindered by the abnormally elevated calcium concentration. No degradation of CLSP in psoriatic epidermis keeping its ability to bind protein as transglutaminase 3 may have a physiological role in skin diseases such as psoriasis.
authors.affiliation: Galderma R&D, Biot, France. bruno.mehul@galderma.com
authors.forename: Bruno
authors.initials: B
authors.lastname: Méhul
authors.forename: Dominique
authors.initials: D
authors.lastname: Bernard
authors.forename: Michel
authors.initials: M
authors.lastname: Brouard
authors.forename: Caroline
authors.initials: C
authors.lastname: Delattre
authors.forename: Rainer
authors.initials: R
authors.lastname: Schmidt
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000595:Amino Acid Sequence; D000911:Antibodies, Monoclonal / Q000096:biosynthesis; D002118:Calcium / Q000378:metabolism* / Q000494:pharmacology; D002135:Calcium-Binding Proteins / Q000235:genetics / Q000276:immunology / Q000378:metabolism*; D002614:Chelating Agents / Q000494:pharmacology; D004817:Epidermis / Q000187:drug effects / Q000378:metabolism; D005260:Female; D006801:Humans; D007150:Immunohistochemistry; D066298:In Vitro Techniques; D008297:Male; D008875:Middle Aged; D010447:Peptide Hydrolases / Q000378:metabolism; D011565:Psoriasis / Q000378:metabolism*; D011994:Recombinant Proteins / Q000235:genetics / Q000276:immunology / Q000378:metabolism; D011503:Transglutaminases / Q000378:metabolism
chemical_list: D000911:Antibodies, Monoclonal; C408467:CALML5 protein, human; D002135:Calcium-Binding Proteins; D002614:Chelating Agents; D011994:Recombinant Proteins; C498712:TGM3 protein, human; D011503:Transglutaminases; D010447:Peptide Hydrolases; D002118:Calcium